Defilade Capital Management, L.P. 13F holdings, Q4 2025
Holdings as of December 31, 2025 · filings on SEC EDGAR · latest filing →
Defilade Capital Management, L.P. disclosed 33 US equity positions worth $737.7m in its Q4 2025 13F filing. The largest position was PFE at 7.4% of the reported book, followed by ABBV and NVS.
What did Defilade Capital Management, L.P. own in Q4 2025? Top 33 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | PFE PFIZER INC | Healthcare | 7.4% | $54.9m | 2,203,504 | – | |
| 2 | ABBV ABBVIE INC | Healthcare | 7.1% | $52.0m | 227,669 | – | |
| 3 | NVS NOVARTIS AG | Healthcare | 6.8% | $50.0m | 362,816 | – | |
| 4 | ICUI ICU MED INC | Healthcare | 6.6% | $48.6m | 340,745 | – | |
| 5 | PACS PACS GROUP INC | Healthcare | 6.0% | $44.0m | 1,145,485 | – | |
| 6 | LLY ELI LILLY & CO | Healthcare | 4.7% | $34.3m | 31,950 | – | |
| 7 | STE STERIS PLC | Healthcare | 4.6% | $34.3m | 135,307 | – | |
| 8 | OLMA OLEMA PHARMACEUTICALS INC | Healthcare | 4.2% | $30.9m | 1,234,634 | – | |
| 9 | RVMD REVOLUTION MEDICINES INC | Healthcare | 3.9% | $28.9m | 363,454 | – | |
| 10 | BIIB BIOGEN INC | Healthcare | 3.9% | $28.5m | 161,992 | – | |
| 11 | NUVALENT INC | 3.7% | $27.1m | 269,043 | – | ||
| 12 | ISRG INTUITIVE SURGICAL INC | Healthcare | 3.5% | $25.9m | 45,662 | – | |
| 13 | HSIC HENRY SCHEIN INC | Healthcare | 3.3% | $24.2m | 320,422 | – | |
| 14 | GMED GLOBUS MED INC | Healthcare | 3.2% | $23.3m | 267,212 | – | |
| 15 | XNCR XENCOR INC | Healthcare | 2.9% | $21.7m | 1,414,755 | – | |
| 16 | COGT COGENT BIOSCIENCES INC | Healthcare | 2.7% | $20.2m | 568,619 | – | |
| 17 | ALGN ALIGN TECHNOLOGY INC | Healthcare | 2.7% | $20.0m | 128,060 | – | |
| 18 | ASND ASCENDIS PHARMA A/S | Healthcare | 2.5% | $18.3m | 85,694 | – | |
| 19 | DXCM DEXCOM INC | Healthcare | 2.2% | $16.3m | 244,881 | – | |
| 20 | BDX BECTON DICKINSON & CO | Healthcare | 2.1% | $15.8m | 81,207 | – | |
| 21 | ATRC ATRICURE INC | Healthcare | 2.1% | $15.7m | 397,636 | – | |
| 22 | LIVN LIVANOVA PLC | Healthcare | 2.0% | $14.9m | 241,413 | – | |
| 23 | ATEC ALPHATEC HLDGS INC | Healthcare | 1.8% | $13.2m | 626,754 | – | |
| 24 | DNLI DENALI THERAPEUTICS INC | Healthcare | 1.5% | $10.8m | 656,713 | – | |
| 25 | GKOS GLAUKOS CORP | Healthcare | 1.4% | $10.4m | 91,703 | – | |
| 26 | RXST RXSIGHT INC | Healthcare | 1.3% | $9.5m | 913,090 | – | |
| 27 | ELAN ELANCO ANIMAL HEALTH INC | Healthcare | 1.2% | $9.1m | 401,283 | – | |
| 28 | INSM INSMED INC | Healthcare | 1.2% | $8.7m | 50,000 | – | |
| 29 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 1.1% | $8.3m | 681,663 | – | |
| 30 | TFX TELEFLEX INCORPORATED | Healthcare | 0.7% | $5.2m | 42,850 | – | |
| 31 | ELDN ELEDON PHARMACEUTICALS INC | 0.7% | $5.0m | 3,290,450 | – | ||
| 32 | CNMD CONMED CORP | Healthcare | 0.6% | $4.2m | 104,129 | – | |
| 33 | EVMN EVOMMUNE INC | 0.5% | $3.7m | 215,418 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.